Markus Puhlmann
Direttore Tecnico/Scientifico/R&S presso PERSPECTIVE THERAPEUTICS, INC.
Patrimonio netto: 2 M $ in data 31/05/2024
Posizioni attive di Markus Puhlmann
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Markus Puhlmann
Precedenti posizioni note di Markus Puhlmann
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | 01/01/2019 | 01/01/2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2015 | 01/01/2019 |
Formazione di Markus Puhlmann
| Ludwig-Maximilians-Universität München | Doctorate Degree |
| McDonough School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Germania | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Borsa valori
- Insiders
- Markus Puhlmann
- Esperienza
